Heron Therapeuti Stock In The News

HRTX Stock  USD 2.65  0.15  5.36%   
The tone or emotional content of news articles related to Heron Therapeuti can affect its prices. Positive news sentiment can lead to an increase in demand for Heron Therapeuti's stock, while negative news sentiment can lead to a decrease in demand. Our overall analysis of Heron Therapeuti's news coverage and content from conventional and social sources shows investors' bearish mood towards Heron Therapeuti. The specific impact of Heron Therapeuti news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Heron Therapeuti's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Heron Therapeuti headlines in addition to utilizing other, more conventional financial analysis modules. Check out Heron Therapeuti Backtesting and Heron Therapeuti Hype Analysis.
For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide.

Heron Therapeuti Today Top News and Investor Outlook

Yahoo News
12 Best Rising Penny Stocks To Buy
https://finance.yahoo.com/news/12-best-rising-penny-stocks-165636339.html
 Bullish
Yahoo News
Heron (HRTX) Gains 19% on FDA Nod for Zynrelef Label Expansion
https://finance.yahoo.com/news/heron-hrtx-gains-19-fda-114400737.html
 Bullish
Yahoo News
Heron Therapeutics' Non-Opioid, Post-Operative Pain Drug Approved For Use In Additional Orthopedic, Soft Tissue Procedures - FDA Gives Nod
https://finance.yahoo.com/news/heron-therapeutics-non-opioid-post-184759722.html
 Neutral
Yahoo News
Heron Therapeutics Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures
https://finance.yahoo.com/news/heron-therapeutics-announces-fda-approval-010000561.html
 Neutral
Yahoo News
Heron Therapeutics, Inc. (NASDAQ:HRTX) is largely controlled by institutional shareholders who own 52% of the company
https://finance.yahoo.com/news/heron-therapeutics-inc-nasdaq-hrtx-111605197.html
 Bullish
Yahoo News
The 3 Most Undervalued Biotech Stocks to Buy in January
https://finance.yahoo.com/news/3-most-undervalued-biotech-stocks-215107832.html
 Bullish
Yahoo News
Heron Therapeutics (HRTX) Just Flashed Golden Cross Signal: Do You Buy?
https://finance.yahoo.com/news/heron-therapeutics-hrtx-just-flashed-145503823.html
 Bullish
Yahoo News
Heron Therapeutics Announces Partnership...
https://finance.yahoo.com/news/heron-therapeutics-announces-partnership-crosslink-220000459.html
 Bullish
Yahoo News
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
https://finance.yahoo.com/news/miyazakis-boy-heron-no-1-172345853.html
 Neutral
Yahoo News
13 Hot Penny Stocks To Buy According to Hedge Funds
https://finance.yahoo.com/news/13-hot-penny-stocks-buy-165640242.html
 Bullish

Heron Therapeuti Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Heron and other traded companies coverage. We help investors stay connected with Heron headlines for the 25th of April to make an informed investment decision based on correlating the impacts of news items on Heron Stock performance. Please note that trading solely based on the Heron Therapeuti hype is not for everyone as timely availability and quick action are needed to avoid losses.
Heron Therapeuti's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Heron Therapeuti investors visualize upcoming and past events in order to time the market based on Heron Therapeuti noise-free hype analysis.
Heron Therapeuti stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Heron earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Heron Therapeuti that are available to investors today. That information is available publicly through Heron media outlets and privately through word of mouth or via Heron internal channels. However, regardless of the origin, that massive amount of Heron data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Heron Therapeuti news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Heron Therapeuti relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Heron Therapeuti's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Heron Therapeuti alpha.

Heron Largest EPS Surprises

Earnings surprises can significantly impact Heron Therapeuti's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-08-09
2022-06-30-0.5-0.55-0.0510 
2023-05-11
2023-03-31-0.2-0.27-0.0735 
2021-08-09
2021-06-30-0.55-0.62-0.0712 
2014-05-08
2014-03-31-0.67-0.74-0.0710 
2020-05-06
2020-03-31-0.65-0.570.0812 
2015-03-13
2014-12-31-0.79-0.710.0810 
View All Earnings Estimates

Heron Therapeuti Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Heron Therapeuti Stock. The global stock market is bearish. About 60% of major world exchanges and indexes are down. See today's market update for more information.
businesswire News
23rd of April 2024
Disposition of 4564 shares by Kimberly Manhard of Heron Therapeuti subject to Rule 16b-3
at businesswire.com 
Macroaxis News
15th of April 2024
Disposition of 42631 shares by Lisa Peraza of Heron Therapeuti subject to Rule 16b-3
at MacroaxisInsider 
news
12th of April 2024
STAT Up and down the ladder The latest comings and goings
at statnews.com 
Macroaxis News
3rd of April 2024
Disposition of 62500 shares by Craig Collard of Heron Therapeuti subject to Rule 16b-3
at MacroaxisInsider 
Google News at Macroaxis
25th of March 2024
Does Heron Therapeutics Inc Have What it Takes to be in Your Portfolio Monday - InvestorsO...
at news.google.com 
news
21st of March 2024
Predicting the Guardians opening day roster with one week left in training camp
at cleveland.com 
Simply Wall St News at Macroaxis
15th of March 2024
Heres What Analysts Are Forecasting For Heron Therapeutics, Inc. After Its Full-Year Resul...
at simplywall.st 
Investing News at Macroaxis
13th of March 2024
Needham raises Heron Therapeutics stock PT to 5 on strong 2023 finish
at investing.com 
Yahoo News
7th of March 2024
Oncternal Therapeutics Reports Q4 Loss, Tops Revenue Estimates
at finance.yahoo.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Heron Therapeuti in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Heron Therapeuti's short interest history, or implied volatility extrapolated from Heron Therapeuti options trading.
When determining whether Heron Therapeuti offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Heron Therapeuti's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Heron Therapeuti Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Heron Therapeuti Stock:
Check out Heron Therapeuti Backtesting and Heron Therapeuti Hype Analysis.
For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Complementary Tools for Heron Stock analysis

When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Transaction History
View history of all your transactions and understand their impact on performance
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Is Heron Therapeuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Heron Therapeuti. If investors know Heron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Heron Therapeuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.80)
Revenue Per Share
0.92
Quarterly Revenue Growth
0.14
Return On Assets
(0.25)
Return On Equity
(24.09)
The market value of Heron Therapeuti is measured differently than its book value, which is the value of Heron that is recorded on the company's balance sheet. Investors also form their own opinion of Heron Therapeuti's value that differs from its market value or its book value, called intrinsic value, which is Heron Therapeuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Heron Therapeuti's market value can be influenced by many factors that don't directly affect Heron Therapeuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Heron Therapeuti's value and its price as these two are different measures arrived at by different means. Investors typically determine if Heron Therapeuti is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Heron Therapeuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.